Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gregory R Friberg Insider Profile
4 Followers
Gregory R Friberg, EVP, Chief R&D Officer at BioMarin Pharmaceutical, holds 29.06K shares in BioMarin Pharmaceutical (Ticker: BMRN).
Gregory R Friberg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gregory R Friberg's holdings
Insider Roles
EVP, Chief R&D Officer
Roles that Gregory R Friberg holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gregory R Friberg
Gregory R Friberg's Trading History
List of latest transactions for each holding click on a transaction to see Gregory R Friberg's performance on stock
You May Also Like
Gregory R Friberg insider profile FAQ
What is the percentage of profitable transactions made by Gregory R Friberg?
The percentage of profitable transactions made by Gregory R Friberg is ―.
What is the average return per transaction made by Gregory R Friberg?
The average return per transaction made by Gregory R Friberg is ―.
What stocks does Gregory R Friberg hold?
Gregory R Friberg holds: BMRN stocks.
What was Gregory R Friberg’s latest transaction?
Gregory R Friberg latest transaction was an Uninformative Buy of ―.
What was Gregory R Friberg's most profitable transaction?
Gregory R Friberg’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gregory R Friberg's role in BioMarin Pharmaceutical?
Gregory R Friberg's role in BioMarin Pharmaceutical is EVP, Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.